NYSE:DVA - Davita Stock Price, Forecast & News

Davita trades on the New York Stock Exchange (NYSE) under the ticker symbol "DVA."

Davita Inc (NYSE:DVA) announced its earnings results on Tuesday, November, 5th. The company reported $1.53 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $1.24 by $0.29. The firm earned $2.90 billion during the quarter, compared to analyst estimates of $2.85 billion. Davita had a net margin of 3.68% and a return on equity of 19.95%. Davita's revenue was up 2.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.56 EPS. View Davita's Earnings History.

Davita is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Davita.

Davita issued an update on its FY20 earnings guidance on Tuesday, November, 5th. The company provided earnings per share (EPS) guidance of $5.25-5.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $5.32.

10 brokers have issued 1-year target prices for Davita's stock. Their forecasts range from $57.00 to $80.00. On average, they expect Davita's stock price to reach $66.17 in the next year. This suggests that the stock has a possible downside of 17.8%. View Analyst Price Targets for Davita.

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Davita in the last year. There are currently 8 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Davita.

Media coverage about DVA stock has trended very positive recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Davita earned a coverage optimism score of 3.9 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Davita.

Davita saw a increase in short interest in the month of December. As of December 13th, there was short interest totalling 8,180,000 shares, an increase of 6.6% from the November 28th total of 7,670,000 shares. Based on an average daily trading volume, of 1,560,000 shares, the days-to-cover ratio is currently 5.2 days. Approximately 6.5% of the shares of the stock are short sold. View Davita's Current Options Chain.

Some companies that are related to Davita include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), Chemed (CHE), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), BioScrip (BIOS), MEDNAX (MD), CorVel (CRVL), R1 RCM (RCM), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Davita investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Chipotle Mexican Grill (CMG), Aegean Marine Petroleum Network (ANW), AutoZone (AZO), Designer Brands (DBI), United Rentals (URI), Micron Technology (MU) and Accenture (ACN).

Davita's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Wedge Capital Management L L P NC (0.47%), Assenagon Asset Management S.A. (0.12%), Mercator Fund Cayman Master LP (0.04%), Bowling Portfolio Management LLC (0.03%), Nisa Investment Advisors LLC (0.02%) and KAMES CAPITAL plc (0.02%). Company insiders that own Davita stock include Charles Berg, Pamela M Arway and William L Roper. View Institutional Ownership Trends for Davita.

DVA stock was sold by a variety of institutional investors in the last quarter, including Wedge Capital Management L L P NC, Zurcher Kantonalbank Zurich Cantonalbank , Meag Munich Ergo Kapitalanlagegesellschaft MBH, Stonebridge Capital Management Inc., CenturyLink Investment Management Co, State of Alaska Department of Revenue, IFM Investors Pty Ltd and Northstar Group Inc.. View Insider Buying and Selling for Davita.

DVA stock was acquired by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A., Mercator Fund Cayman Master LP, Bowling Portfolio Management LLC, KAMES CAPITAL plc, Baxter Bros Inc., Baxter Bros Inc., Convergence Investment Partners LLC and Janney Montgomery Scott LLC. View Insider Buying and Selling for Davita.

Shares of DVA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DVA stock can currently be purchased for approximately $80.50.

Davita has a market capitalization of $10.31 billion and generates $11.40 billion in revenue each year. The company earns $159.39 million in net income (profit) each year or $3.57 on an earnings per share basis. Davita employs 77,700 workers across the globe.View Additional Information About Davita.

The official website for Davita is http://www.davita.com/.

Davita's mailing address is 2000 16TH STREET, DENVER CO, 80202. The company can be reached via phone at 720-631-2100 or via email at [email protected]